2026 NPPES data Hematology & Oncology Physician NPI 1164723508 MD
Verify on CMS →

MYRNA ANDINO-CAMACHO, MD

Hematology & Oncology Physician in BAYAMON, Puerto Rico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 158 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
70.0667/100
▼ 13 pts below national avg 83.1 · [object Object]
Industry payments
$2.9K
123 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MYRNA ANDINO-CAMACHO, MD is a Hematology & Oncology Physician ([object Object]) practicing in BAYAMON, Puerto Rico with a Medicare Part D prescribing footprint of 1K claims across 158 beneficiaries — 28% brand-name prescribing . Their CMS MIPS Final Score of 70.0667/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $2.9K across 123 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MYRNA ANDINO-CAMACHO, MD reported a CMS MIPS final score of 70.0667 out of 100, below the 83.1 national average, and filed 1,302 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MYRNA ANDINO-CAMACHO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MYRNA ANDINO-CAMACHO, MD at a glance

Below national average

NPI registry status

Active

Issued 11/16/2010

NPI 1164723508

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,302 54% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

70.0667/100 13.033299999999997% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Puerto Rico

How Hematology & Oncology Physician compares to other specialties among Puerto Rico providers

Puerto Rico providers

Hematology & Oncology Physician share within Puerto Rico

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Puerto Rico

Medicare quality performance — MIPS

MYRNA ANDINO-CAMACHO, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
70.0667/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 70.0667/100 vs national avg 83.1

0%100%National avg83%70.1%
MIPS final score (Hematology & Oncology Physician) — 70.0667/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MYRNA ANDINO-CAMACHO, MD is a Hematology & Oncology Physician provider practicing in BAYAMON, Puerto Rico, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1164723508. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MYRNA ANDINO-CAMACHO, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 135 VILLA DE LA FUENTE, BAYAMON, PR, 00959, with a listed phone of (787) 368-0470. NPI 1164723508 was issued on 11/16/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ANDINO-CAMACHO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,302 prescription claims written by this provider, covering 158 Medicare beneficiaries and totaling roughly $4.2 million in drug spend, split 28% brand-name and 72% generic by claim count, with an opioid prescribing rate of 5.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 70.0667/100 for the 2023 performance year (Quality 39.8455), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

135 VILLA DE LA FUENTE
BAYAMON, PR 00959

Provider Details

NPI 1164723508
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 11/16/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

70.0667
Final Score
Avg: 83.1
39.8455
Quality
99
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MYRNA ANDINO-CAMACHO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ADVANCED HEMATOLOGY AND ONCOLOGY OF PUERTO RICO
CAGUAS, PR

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MYRNA ANDINO-CAMACHO, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.9K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

MYRNA ANDINO-CAMACHO, MD — brand share 28.0%
Specialty average (est.)

28% brand-name claims vs 72% generic, on 1,302 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,302
Total Claims
$4.2M
Total Drug Cost
158
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,378
Total Day Supply
36,041
Brand vs Generic
28% brand / 72% generic
Brand Drug Cost
$4.0M
Generic Drug Cost
$182K
Opioid Claims
70 (5.4% rate)
Antibiotic Claims
38

Patient Demographics

Average Patient Age
72.1 years
Avg HCC Risk Score
2.55
Gender Split
73% female / 27% male
Age Distribution
<65: 26, 65-74: 66, 75-84: 53, 85+: 13

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
319
Dexamethasone
65
Prednisone
53
Tagrisso
Osimertinib Mesylate
32
Letrozole
31
Ibrance
Palbociclib
29
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
29
Warfarin Sodium
27
Zejula
Niraparib Tosylate
26
Keytruda
Pembrolizumab
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MYRNA ANDINO-CAMACHO, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MYRNA ANDINO-CAMACHO, MD's 1,302 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Puerto Rico

Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as ANDINO-CAMACHO.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MYRNA ANDINO-CAMACHO, MD's specialty?
MYRNA ANDINO-CAMACHO, MD specializes in Hematology & Oncology Physician and practices in BAYAMON, Puerto Rico. Credentials: MD.
How much does MYRNA ANDINO-CAMACHO, MD prescribe under Medicare Part D?
In 2023, MYRNA ANDINO-CAMACHO, MD wrote 1,302 Medicare Part D claims totaling $4.2M in drug costs for 158 beneficiaries.
What is MYRNA ANDINO-CAMACHO, MD's Medicare quality score?
MYRNA ANDINO-CAMACHO, MD has a CMS MIPS Final Score of 70.0667/100 (Quality: 39.8455). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MYRNA ANDINO-CAMACHO, MD located?
MYRNA ANDINO-CAMACHO, MD is located at 135 VILLA DE LA FUENTE, BAYAMON, PR, 00959. Phone: (787) 368-0470.
What is MYRNA ANDINO-CAMACHO, MD's NPI number?
MYRNA ANDINO-CAMACHO, MD's National Provider Identifier (NPI) is 1164723508, issued on 11/16/2010.
Does MYRNA ANDINO-CAMACHO, MD prescribe more brand-name or generic drugs?
MYRNA ANDINO-CAMACHO, MD's prescribing is 28% brand-name and 72% generic drugs by claim count, with $4.0M in brand drug costs.
Does MYRNA ANDINO-CAMACHO, MD prescribe opioids?
Yes, MYRNA ANDINO-CAMACHO, MD had 70 opioid claims in 2023 with an opioid prescribing rate of 5.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MYRNA ANDINO-CAMACHO, MD prescribe most often?
Based on 2023 Medicare Part D data, MYRNA ANDINO-CAMACHO, MD's most frequently prescribed drugs include Anastrozole, Dexamethasone, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MYRNA ANDINO-CAMACHO, MD accept Medicare?
MYRNA ANDINO-CAMACHO, MD appears in CMS Medicare data with 1,302 Part D claims and 158 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MYRNA ANDINO-CAMACHO, MD's credentials?
MYRNA ANDINO-CAMACHO, MD's NPI is 1164723508 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology